首页 > 最新文献

Annals of Medicine and Surgery最新文献

英文 中文
Comparing postoperative pain relief: ketorolac and Nasocalcin spray versus lidocaine and Nasocalcin spray in abdominal surgery patients. 比较腹部手术患者的术后镇痛效果:酮咯酸和鼻卡因喷雾剂与利多卡因和鼻卡因喷雾剂。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002285
Masoud Saadat Fakhr, Mahdiya Qasemi, Kiana Rezvanfar, Reza Shah Hosseini, Zahra Amini, Koosha Amiri, Mahan Zhaleh, Taraneh Tarkashvand, Mahnaz Narimani Zamanabadi

Objectives: Postoperative pain management is critical for patient recovery after abdominal surgery. This study compared intravenous lidocaine and ketorolac for reducing postoperative pain and opioid use, along with Nasocalcin nasal spray.

Methods: In this randomized controlled trial, 58 abdominal surgery patients were allocated to receive either intravenous lidocaine plus Nasocalcin spray (n=29) or intravenous ketorolac plus Nasocalcin spray (n=29) before surgery. Pain intensity (visual analog scale) and postoperative opioid consumption were assessed at 1, 6, 12, and 24 h after surgery.

Results: Patients receiving ketorolac plus Nasocalcin spray reported significantly lower pain scores at all time points compared to lidocaine plus Nasocalcin (P<0.001). Average 24-h pain scores were 4.5 with ketorolac versus 5.1 with lidocaine. Mean opioid consumption was also lower in the ketorolac group (31.9 mg) versus the lidocaine group (43.9 mg, P<0.001).

Conclusion: Preoperative ketorolac plus Nasocalcin nasal spray resulted in superior pain relief and less opioid use compared to lidocaine plus Nasocalcin after abdominal surgery. Ketorolac may be a more effective analgesic option, while Nasocalcin spray is a safe adjunct. These findings can inform clinical practice for optimizing postoperative analgesia.

目的:术后疼痛管理对腹部手术后患者的恢复至关重要。本研究比较了静脉注射利多卡因和酮咯酸,以及鼻腔喷雾剂 Nasocalcin 在减少术后疼痛和阿片类药物使用方面的作用:在这项随机对照试验中,58 名腹部手术患者在手术前被分配接受静脉注射利多卡因加 Nasocalcin 喷雾剂(29 人)或静脉注射酮咯酸加 Nasocalcin 喷雾剂(29 人)。术后1、6、12和24小时对疼痛强度(视觉模拟量表)和术后阿片类药物消耗量进行评估:结果:与利多卡因加纳索卡因(PPConclusion)相比,接受酮咯酸加纳索卡因喷雾剂治疗的患者在所有时间点的疼痛评分都明显较低:与利多卡因加纳索卡因相比,腹部手术后术前酮咯酸加纳索卡因鼻腔喷雾剂能更好地缓解疼痛,并减少阿片类药物的使用。酮咯酸可能是一种更有效的镇痛选择,而纳钙霉素喷雾剂则是一种安全的辅助药物。这些发现可为优化术后镇痛的临床实践提供参考。
{"title":"Comparing postoperative pain relief: ketorolac and Nasocalcin spray versus lidocaine and Nasocalcin spray in abdominal surgery patients.","authors":"Masoud Saadat Fakhr, Mahdiya Qasemi, Kiana Rezvanfar, Reza Shah Hosseini, Zahra Amini, Koosha Amiri, Mahan Zhaleh, Taraneh Tarkashvand, Mahnaz Narimani Zamanabadi","doi":"10.1097/MS9.0000000000002285","DOIUrl":"10.1097/MS9.0000000000002285","url":null,"abstract":"<p><strong>Objectives: </strong>Postoperative pain management is critical for patient recovery after abdominal surgery. This study compared intravenous lidocaine and ketorolac for reducing postoperative pain and opioid use, along with Nasocalcin nasal spray.</p><p><strong>Methods: </strong>In this randomized controlled trial, 58 abdominal surgery patients were allocated to receive either intravenous lidocaine plus Nasocalcin spray (<i>n</i>=29) or intravenous ketorolac plus Nasocalcin spray (<i>n</i>=29) before surgery. Pain intensity (visual analog scale) and postoperative opioid consumption were assessed at 1, 6, 12, and 24 h after surgery.</p><p><strong>Results: </strong>Patients receiving ketorolac plus Nasocalcin spray reported significantly lower pain scores at all time points compared to lidocaine plus Nasocalcin (<i>P</i><0.001). Average 24-h pain scores were 4.5 with ketorolac versus 5.1 with lidocaine. Mean opioid consumption was also lower in the ketorolac group (31.9 mg) versus the lidocaine group (43.9 mg, <i>P</i><0.001).</p><p><strong>Conclusion: </strong>Preoperative ketorolac plus Nasocalcin nasal spray resulted in superior pain relief and less opioid use compared to lidocaine plus Nasocalcin after abdominal surgery. Ketorolac may be a more effective analgesic option, while Nasocalcin spray is a safe adjunct. These findings can inform clinical practice for optimizing postoperative analgesia.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidental detection of three testes while evaluating an empty left scrotal sac: a case report. 在评估左侧阴囊空囊时意外发现三个睾丸:病例报告。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002510
Munna William, Amrit Bhusal, Waqar Ahmad, Abdul Sattar Anjum, Usman Qadeer

Introduction and importance: Poly-orchidism is a rare congenital anomaly of the genitourinary system, which is characterized by the presence of more than two testicles, also being termed as "supernumerary testis". Tri-orchidism is the most frequently encountered form of poly-orchidism, which is defined as the presence of more than two intra- or extra-scrotal testicles.

Case presentation: The authors present a case of a 16-year-old male who presented with a complaint of an empty left scrotal sac, and was later diagnosed as a case of tri-orchidism with each testis in bilateral hemipelvis confirmed by ultrasound with Doppler and MRI. The patient was kept in regular follow-up for 6 months with radiological assessment, which showed no changes in radiological findings as before.

Clinical discussion: The majority of patients are asymptomatic or present with a painless inguinal or scrotal mass, undescended testis, and rarely torsion of the supernumerary testis. Imaging modalities like US, Doppler study, and MRI are required for the diagnosis. Non-scrotal location of poly-orchidism is considered as the most important risk factor for malignancy. The surgical approach is required for any malignant changes in biopsy, US showing features of malignancy, absent spermatogenesis or in cases where regular follow-up is not possible. Otherwise, a conservative approach with regular follow-up is enough if above indications are absent.

Conclusion: The complications of poly-orchidism like undescended testes, inguinal hernia, infertility, and possibly malignancy must be borne in mind while diagnosing poly-orchidism. The above-mentioned aspects must also be considered while choosing surgical intervention versus a conservative approach with follow-up, depending upon the position of the supernumerary testicle being scrotal or ectopic.

导言和重要性:多睾症是一种罕见的泌尿生殖系统先天性异常,其特征是存在两个以上的睾丸,也被称为 "超常睾丸"。三睾丸症是多睾丸症中最常见的一种,其定义是阴囊内或阴囊外存在两个以上的睾丸:作者介绍了一例 16 岁男性病例,患者主诉左侧阴囊空囊,后经超声多普勒和核磁共振检查确诊为三睾丸症,每个睾丸位于双侧半睾丸。临床讨论:临床讨论:大多数患者无症状或表现为无痛性腹股沟或阴囊肿块、睾丸下降不明显,极少数患者会出现超常睾丸扭转。诊断时需要进行 US、多普勒检查和 MRI 等影像学检查。非阴囊位置的多睾症被认为是恶性肿瘤最重要的风险因素。如果活组织检查发现任何恶性病变,或 US 显示恶性病变特征,或精子发生缺失,或无法定期随访,则需要进行手术治疗。否则,如果没有上述指征,采取保守治疗和定期随访就足够了:结论:在诊断多睾丸症时,必须注意多睾丸症的并发症,如睾丸下降不全、腹股沟疝、不育症以及可能的恶性肿瘤。在选择手术治疗还是保守随访方法时,也必须考虑上述方面,这取决于赘生睾丸的位置是阴囊还是异位。
{"title":"Incidental detection of three testes while evaluating an empty left scrotal sac: a case report.","authors":"Munna William, Amrit Bhusal, Waqar Ahmad, Abdul Sattar Anjum, Usman Qadeer","doi":"10.1097/MS9.0000000000002510","DOIUrl":"10.1097/MS9.0000000000002510","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Poly-orchidism is a rare congenital anomaly of the genitourinary system, which is characterized by the presence of more than two testicles, also being termed as \"supernumerary testis\". Tri-orchidism is the most frequently encountered form of poly-orchidism, which is defined as the presence of more than two intra- or extra-scrotal testicles.</p><p><strong>Case presentation: </strong>The authors present a case of a 16-year-old male who presented with a complaint of an empty left scrotal sac, and was later diagnosed as a case of tri-orchidism with each testis in bilateral hemipelvis confirmed by ultrasound with Doppler and MRI. The patient was kept in regular follow-up for 6 months with radiological assessment, which showed no changes in radiological findings as before.</p><p><strong>Clinical discussion: </strong>The majority of patients are asymptomatic or present with a painless inguinal or scrotal mass, undescended testis, and rarely torsion of the supernumerary testis. Imaging modalities like US, Doppler study, and MRI are required for the diagnosis. Non-scrotal location of poly-orchidism is considered as the most important risk factor for malignancy. The surgical approach is required for any malignant changes in biopsy, US showing features of malignancy, absent spermatogenesis or in cases where regular follow-up is not possible. Otherwise, a conservative approach with regular follow-up is enough if above indications are absent.</p><p><strong>Conclusion: </strong>The complications of poly-orchidism like undescended testes, inguinal hernia, infertility, and possibly malignancy must be borne in mind while diagnosing poly-orchidism. The above-mentioned aspects must also be considered while choosing surgical intervention versus a conservative approach with follow-up, depending upon the position of the supernumerary testicle being scrotal or ectopic.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ogilvie syndrome with caecal perforation following cesarean section: a rare case report from Jordan. 剖腹产后伴有盲肠穿孔的奥格尔维综合征:来自约旦的罕见病例报告。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002524
Rawan A Obeidat, Sakhr Alshwayyat, Tala Alshwayyat, Ahmad Abdulla, Almoutuz Aljaafreh, Hamdah Hanifa

Introduction: Ogilvie syndrome is a rare condition characterized by acute colonic dilation. In 1948, H. Ogilvie first described it in medical literature. Its incidence is estimated at 100 cases per 100 000 per year in the US. Both abdominal distention and pain are considered major symptoms.

Presentation of case: A 32-year-old woman, 36+1 weeks pregnant, experienced labour pain and was admitted to the hospital. Upon examination, she was in labour, but the foetus was in a breech position, necessitating a caesarean section. After 36 h later, she returned to the emergency department with severe, 1-day-old diffuse abdominal pain, accompanied by moderate bilious vomiting and significant abdominal distension. Abdominal CT with contrast revealed pneumoperitoneum, abdominal wall emphysema, and pneumatosis intestinalis involving the caecum and ascending colon, suggesting bowel necrosis. Emergency laparotomy revealed a caecal perforation, which was closed surgically without resection.

Clinical discussion: Ogilvie syndrome is more common in males but can occur in females for several reasons, including pregnancy, caesarean section, pelvic surgeries, and trauma. Several factors contribute to the occurrence of this syndrome, such as pelvic fractures and cardiac events. Surgery may be required if there is suspicion of bowel perforation or ischaemia.

Conclusion: OS is a rare condition in women, often seen after childbirth or pelvic surgery, with an unclear cause but believed to be related to autonomic nervous system imbalance. Patients with abdominal pain and distension, without evidence of obstruction, should be evaluated for pseudo-obstruction using abdominal pelvic CT, and treatment may involve conservative measures, medication, and colonoscopic decompression.

简介奥格尔维综合征是一种以急性结肠扩张为特征的罕见疾病。1948 年,H. Ogilvie 首次在医学文献中描述了这种疾病。在美国,其发病率估计为每年每 10 万人中有 100 例。腹胀和腹痛被认为是主要症状:一名怀孕 36+1 周的 32 岁女性因分娩疼痛而入院。经检查,她已经分娩,但胎儿呈臀位,因此必须进行剖腹产。36 小时后,她因 1 天前出现的剧烈弥漫性腹痛,伴有中度胆汁性呕吐和明显腹胀,再次来到急诊科就诊。造影剂腹部CT显示腹腔积气、腹壁气肿、肠道积气累及盲肠和升结肠,提示肠道坏死。急诊开腹手术发现了盲肠穿孔,手术缝合后未进行切除:临床讨论:奥格尔维综合征多见于男性,但也可能因怀孕、剖腹产、骨盆手术和外伤等多种原因而发生在女性身上。骨盆骨折和心脏事件等多种因素会导致该综合征的发生。如果怀疑有肠穿孔或缺血,可能需要进行手术:OS是一种罕见的女性病症,常见于分娩或盆腔手术后,病因不明,但据信与自主神经系统失衡有关。对于腹痛、腹胀但无梗阻证据的患者,应使用腹部盆腔 CT 评估是否存在假性梗阻,治疗方法可包括保守治疗、药物治疗和结肠镜减压术。
{"title":"Ogilvie syndrome with caecal perforation following cesarean section: a rare case report from Jordan.","authors":"Rawan A Obeidat, Sakhr Alshwayyat, Tala Alshwayyat, Ahmad Abdulla, Almoutuz Aljaafreh, Hamdah Hanifa","doi":"10.1097/MS9.0000000000002524","DOIUrl":"10.1097/MS9.0000000000002524","url":null,"abstract":"<p><strong>Introduction: </strong>Ogilvie syndrome is a rare condition characterized by acute colonic dilation. In 1948, H. Ogilvie first described it in medical literature. Its incidence is estimated at 100 cases per 100 000 per year in the US. Both abdominal distention and pain are considered major symptoms.</p><p><strong>Presentation of case: </strong>A 32-year-old woman, 36+1 weeks pregnant, experienced labour pain and was admitted to the hospital. Upon examination, she was in labour, but the foetus was in a breech position, necessitating a caesarean section. After 36 h later, she returned to the emergency department with severe, 1-day-old diffuse abdominal pain, accompanied by moderate bilious vomiting and significant abdominal distension. Abdominal CT with contrast revealed pneumoperitoneum, abdominal wall emphysema, and pneumatosis intestinalis involving the caecum and ascending colon, suggesting bowel necrosis. Emergency laparotomy revealed a caecal perforation, which was closed surgically without resection.</p><p><strong>Clinical discussion: </strong>Ogilvie syndrome is more common in males but can occur in females for several reasons, including pregnancy, caesarean section, pelvic surgeries, and trauma. Several factors contribute to the occurrence of this syndrome, such as pelvic fractures and cardiac events. Surgery may be required if there is suspicion of bowel perforation or ischaemia.</p><p><strong>Conclusion: </strong>OS is a rare condition in women, often seen after childbirth or pelvic surgery, with an unclear cause but believed to be related to autonomic nervous system imbalance. Patients with abdominal pain and distension, without evidence of obstruction, should be evaluated for pseudo-obstruction using abdominal pelvic CT, and treatment may involve conservative measures, medication, and colonoscopic decompression.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444571/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes and complications of percutaneous nephrolithotomy as primary versus secondary procedure for kidney stones: a prospective cohort study. 经皮肾镜取石术作为治疗肾结石的主要手术与次要手术的疗效和并发症:一项前瞻性队列研究。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002502
Aymen Sakly, Syrine Khaldi, Anouar Touati, Elyes Dimassi, Walid Zakhama, Yassine Binous

Introduction: Currently, percutaneous nephrolithotomy (PCNL) is the gold standard of treatment for large renal stones. The high prevalence of urolithiasis is associated with a high recurrence rate increasing the risk of re-intervention. This study aimed to compare the effectiveness and complications of PCNL among patients with previous therapeutic interventions for renal stones.

Methods: Between August 2018 and September 2023, 245 patients were prospectively enrolled in this study and who underwent PCNL for renal stones at our institution. We compared patients who had no previous renal surgery (group 1: n=171) with those who had a history of open renal surgery (group 2: n=45) or previous PCNL on the ipsilateral kidney (group 3: n=31). All patients underwent surgery in the Galdakao-modified Valdivia position. Data on stone characteristics and perioperative and postoperative parameters were collected. Technical features, success rates and morbidity were analyzed and compared between the groups.

Results: The fluoroscopy time was significantly longer in the group of patients with previous open surgery than in groups 1 and 3 (161.47±52.44, 223.05±33.29, 172.27±30.51 sec, P<0.001). Similarly, the operative time was longer in group 2 (138.20±38.86 min, P<0.001). The immediate stone-free rates in groups 1, 2, and 3 were 74.8%, 72.1%, and 77.4%, respectively (P=0.945). At 1-month, these rates increased to 98.8%, 96.2% and 96.8%, respectively (P=0.857). No difference was detected between the groups in terms of complication rate. The average Hb variation was 1.08±0.82, 1.34±1.01 and 0.94±0.69 g/dl for groups 1, 2 and 3, respectively(P=0.082). Hospital stay was longer in group 2 than in groups 1 and 3 (2.17±1.03, 2.53±1.22, 1.88±1.00 days, P=0.07), respectively.

Conclusion: PCNL in patients with a history of renal surgery was associated with longer fluoroscopy and operative time. However, the success and morbidity rates as a secondary procedure were similar to those of PCNL in patients with no previous intervention.

导言:目前,经皮肾镜取石术(PCNL)是治疗大块肾结石的金标准。尿路结石的高发病率与高复发率有关,增加了再次介入治疗的风险。本研究旨在比较PCNL在既往接受过肾结石治疗干预的患者中的有效性和并发症:2018年8月至2023年9月期间,245名患者被前瞻性纳入本研究,并在我院接受了肾结石PCNL治疗。我们将既往未接受过肾脏手术的患者(第1组:n=171)与既往接受过开放性肾脏手术的患者(第2组:n=45)或既往接受过同侧肾脏PCNL的患者(第3组:n=31)进行了比较。所有患者均采用 Galdakao 改良 Valdivia 体位进行手术。收集了结石特征、围术期和术后参数的数据。对各组的技术特点、成功率和发病率进行了分析和比较:结果:曾接受过开放手术的患者组的透视时间明显长于第 1 组和第 3 组(161.47±52.44 秒、223.05±33.29 秒、172.27±30.51 秒,PPP=0.945)。1 个月后,这些比率分别增至 98.8%、96.2% 和 96.8%(P=0.857)。两组在并发症发生率方面未发现差异。第 1、2 和 3 组的平均血红蛋白变化分别为 1.08±0.82、1.34±1.01 和 0.94±0.69 g/dl(P=0.082)。第 2 组的住院时间比第 1 组和第 3 组长(分别为 2.17±1.03、2.53±1.22、1.88±1.00 天,P=0.07):有肾脏手术史的患者 PCNL 需要更长的透视和手术时间。不过,作为二次手术,其成功率和发病率与未接受过干预的 PCNL 患者相似。
{"title":"Outcomes and complications of percutaneous nephrolithotomy as primary versus secondary procedure for kidney stones: a prospective cohort study.","authors":"Aymen Sakly, Syrine Khaldi, Anouar Touati, Elyes Dimassi, Walid Zakhama, Yassine Binous","doi":"10.1097/MS9.0000000000002502","DOIUrl":"10.1097/MS9.0000000000002502","url":null,"abstract":"<p><strong>Introduction: </strong>Currently, percutaneous nephrolithotomy (PCNL) is the gold standard of treatment for large renal stones. The high prevalence of urolithiasis is associated with a high recurrence rate increasing the risk of re-intervention. This study aimed to compare the effectiveness and complications of PCNL among patients with previous therapeutic interventions for renal stones.</p><p><strong>Methods: </strong>Between August 2018 and September 2023, 245 patients were prospectively enrolled in this study and who underwent PCNL for renal stones at our institution. We compared patients who had no previous renal surgery (group 1: <i>n</i>=171) with those who had a history of open renal surgery (group 2: <i>n</i>=45) or previous PCNL on the ipsilateral kidney (group 3: <i>n</i>=31). All patients underwent surgery in the Galdakao-modified Valdivia position. Data on stone characteristics and perioperative and postoperative parameters were collected. Technical features, success rates and morbidity were analyzed and compared between the groups.</p><p><strong>Results: </strong>The fluoroscopy time was significantly longer in the group of patients with previous open surgery than in groups 1 and 3 (161.47±52.44, 223.05±33.29, 172.27±30.51 sec, <i>P</i><0.001). Similarly, the operative time was longer in group 2 (138.20±38.86 min, <i>P</i><0.001). The immediate stone-free rates in groups 1, 2, and 3 were 74.8%, 72.1%, and 77.4%, respectively (<i>P</i>=0.945). At 1-month, these rates increased to 98.8%, 96.2% and 96.8%, respectively (<i>P</i>=0.857). No difference was detected between the groups in terms of complication rate. The average Hb variation was 1.08±0.82, 1.34±1.01 and 0.94±0.69 g/dl for groups 1, 2 and 3, respectively(<i>P</i>=0.082). Hospital stay was longer in group 2 than in groups 1 and 3 (2.17±1.03, 2.53±1.22, 1.88±1.00 days, <i>P</i>=0.07), respectively.</p><p><strong>Conclusion: </strong>PCNL in patients with a history of renal surgery was associated with longer fluoroscopy and operative time. However, the success and morbidity rates as a secondary procedure were similar to those of PCNL in patients with no previous intervention.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep brain stimulation for post-stroke rehabilitation in Pakistan. 巴基斯坦用于中风后康复的深部脑刺激疗法。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002511
Muhammad Idrees, Muskan A Taimuri, Ayesha Azhar, Najam A Khan, Umme Kalsoom, Aiman Sajid, Aymar Akilimali

Stroke has a high prevalence in Pakistan, at an alarming rate of 250 per 100 000 people. Although various treatment options are available, they are not ideal for Pakistan due to their high cost, restricted availability, and time sensitivity. In 1997, the FDA-approved deep brain stimulation (DBS) for Parkinson's disease and it was first performed in Pakistan in 2014. DBS has also proved effective for restoring post-stroke mobility, according to a trial from August 2023. DBS has the potential to revolutionize post-stroke rehabilitation in Pakistan; however, further research is required into its effectiveness and its limitations must be addressed first.

中风在巴基斯坦的发病率很高,达到惊人的每 10 万人 250 例。虽然有各种治疗方案,但由于费用高昂、可用性受限和时间敏感性,这些方案在巴基斯坦并不理想。1997 年,美国食品和药物管理局批准了帕金森病的脑深部刺激术(DBS),并于 2014 年首次在巴基斯坦实施。根据 2023 年 8 月的一项试验,深部脑刺激也被证明对恢复中风后的行动能力有效。脑深部刺激术有可能彻底改变巴基斯坦的脑卒中后康复治疗;然而,还需要进一步研究其有效性,而且必须首先解决其局限性。
{"title":"Deep brain stimulation for post-stroke rehabilitation in Pakistan.","authors":"Muhammad Idrees, Muskan A Taimuri, Ayesha Azhar, Najam A Khan, Umme Kalsoom, Aiman Sajid, Aymar Akilimali","doi":"10.1097/MS9.0000000000002511","DOIUrl":"10.1097/MS9.0000000000002511","url":null,"abstract":"<p><p>Stroke has a high prevalence in Pakistan, at an alarming rate of 250 per 100 000 people. Although various treatment options are available, they are not ideal for Pakistan due to their high cost, restricted availability, and time sensitivity. In 1997, the FDA-approved deep brain stimulation (DBS) for Parkinson's disease and it was first performed in Pakistan in 2014. DBS has also proved effective for restoring post-stroke mobility, according to a trial from August 2023. DBS has the potential to revolutionize post-stroke rehabilitation in Pakistan; however, further research is required into its effectiveness and its limitations must be addressed first.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laryngotracheal stenosis: a single-center retrospective analysis of endoscopic treatment strategies and recurrence. 喉气管狭窄:对内窥镜治疗策略和复发的单中心回顾性分析。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002486
Ekhlass Abu Asabeh, Zahraa M M Zeer, Mayar Idkedek, Salam Qumsieh, Maher Deeb, Yousef Abu Asbeh

Background: Laryngotracheal stenosis is a process of fibrosis that results in airway obstruction; it may be congenital or acquired. Acquired cases are due to iatrogenic, traumatic, infectious and autoimmune causes. Patients present with a spectrum of breathing difficulties that might be fatal.

Objectives: This article presents a unique retrospective cross-sectional study of patients with laryngotracheal stenosis who had endoscopic dilatation, and some had open surgical procedures to describe the evolution after the therapy, to compare the outcomes of the dilatation in comparison to surgical interventions and associated complications in other studies, to provide knowledge to help in dealing with these patients, and to enable educated, independent patient decision-making.

Material and methods: In this observational and descriptive study, we aimed to highlight the clinical features, management, and treatment outcomes among twenty-nine patients with laryngotracheal stenosis who were managed by open and endoscopic surgical intervention over a period of 5 years. Data were collected retrospectively from the patients' medical records from February 2016 until July 2022 at a hospital in Jerusalem, which is a tertiary healthcare facility and the only referral center for similar cases from the West Bank, East Jerusalem, and Gaza, with a population of around 8 million. Tables and graphs are used to highlight the statistical study's findings. Data were analyzed using Microsoft Excel software.

Results: Twenty-nine patients were involved in the study, with an average age of 32.2 years; 51.7% of them were males. The patients had one or more chronic conditions, such as hypertension and coronary artery disease. The majority of patients (65.5%) had stenosis as a result of orotracheal intubation, and the most common site was the subglottic (68.9%). According to the Cotton-Myer classification, 44.8% of the patients were classified in grade III, 34.4% were included in grade I, 13.7% in grade II, and 6.8% in grade IV. Six patients (20.68%) received surgery for stenosis, and 23 patients had an endo-laryngeal dilatation. Restenosis happened in (58.6%). Mortality rates are almost negligible.

Conclusion: Subglottic stenosis is still a challenging condition to manage. The authors describe a single-center experience approach dealing with these conditions. Long-term follow-up for these cases is mandatory as the recurrence rate is still high.

背景:喉气管狭窄是一种导致气道阻塞的纤维化过程;它可能是先天性的,也可能是后天性的。获得性病例由先天性、创伤性、感染性和自身免疫性原因引起。患者会出现一系列呼吸困难,甚至可能致命:本文对喉气管狭窄患者进行了一项独特的回顾性横断面研究,这些患者接受了内窥镜扩张术,还有一些患者接受了开放性外科手术,目的是描述治疗后的演变情况,将扩张术的结果与其他研究中的外科手术干预和相关并发症进行比较,提供有助于处理这些患者的知识,使患者能够在知情的情况下独立做出决定:在这项观察性和描述性研究中,我们旨在强调 29 名喉气管狭窄患者的临床特征、管理和治疗结果,这些患者在 5 年内接受了开放式和内窥镜手术治疗。数据来自耶路撒冷一家医院从 2016 年 2 月到 2022 年 7 月期间患者病历的回顾性收集,该医院是一家三级医疗机构,也是约旦河西岸、东耶路撒冷和加沙地带类似病例的唯一转诊中心,人口约 800 万。本报告使用表格和图表来突出说明统计研究的结果。数据使用 Microsoft Excel 软件进行分析:研究涉及 29 名患者,平均年龄为 32.2 岁,其中 51.7% 为男性。患者患有一种或多种慢性疾病,如高血压和冠心病。大多数患者(65.5%)因气管插管导致气管狭窄,最常见的部位是声门下(68.9%)。根据 Cotton-Myer 分级法,44.8% 的患者属于 III 级,34.4% 属于 I 级,13.7% 属于 II 级,6.8% 属于 IV 级。6名患者(20.68%)接受了狭窄手术,23名患者接受了喉内扩张术。再狭窄发生率为 58.6%。死亡率几乎可以忽略不计:结论:声门下狭窄仍然是一种具有挑战性的疾病。作者描述了单中心处理这些病症的经验。由于复发率仍然很高,因此必须对这些病例进行长期随访。
{"title":"Laryngotracheal stenosis: a single-center retrospective analysis of endoscopic treatment strategies and recurrence.","authors":"Ekhlass Abu Asabeh, Zahraa M M Zeer, Mayar Idkedek, Salam Qumsieh, Maher Deeb, Yousef Abu Asbeh","doi":"10.1097/MS9.0000000000002486","DOIUrl":"10.1097/MS9.0000000000002486","url":null,"abstract":"<p><strong>Background: </strong>Laryngotracheal stenosis is a process of fibrosis that results in airway obstruction; it may be congenital or acquired. Acquired cases are due to iatrogenic, traumatic, infectious and autoimmune causes. Patients present with a spectrum of breathing difficulties that might be fatal.</p><p><strong>Objectives: </strong>This article presents a unique retrospective cross-sectional study of patients with laryngotracheal stenosis who had endoscopic dilatation, and some had open surgical procedures to describe the evolution after the therapy, to compare the outcomes of the dilatation in comparison to surgical interventions and associated complications in other studies, to provide knowledge to help in dealing with these patients, and to enable educated, independent patient decision-making.</p><p><strong>Material and methods: </strong>In this observational and descriptive study, we aimed to highlight the clinical features, management, and treatment outcomes among twenty-nine patients with laryngotracheal stenosis who were managed by open and endoscopic surgical intervention over a period of 5 years. Data were collected retrospectively from the patients' medical records from February 2016 until July 2022 at a hospital in Jerusalem, which is a tertiary healthcare facility and the only referral center for similar cases from the West Bank, East Jerusalem, and Gaza, with a population of around 8 million. Tables and graphs are used to highlight the statistical study's findings. Data were analyzed using Microsoft Excel software.</p><p><strong>Results: </strong>Twenty-nine patients were involved in the study, with an average age of 32.2 years; 51.7% of them were males. The patients had one or more chronic conditions, such as hypertension and coronary artery disease. The majority of patients (65.5%) had stenosis as a result of orotracheal intubation, and the most common site was the subglottic (68.9%). According to the Cotton-Myer classification, 44.8% of the patients were classified in grade III, 34.4% were included in grade I, 13.7% in grade II, and 6.8% in grade IV. Six patients (20.68%) received surgery for stenosis, and 23 patients had an endo-laryngeal dilatation. Restenosis happened in (58.6%). Mortality rates are almost negligible.</p><p><strong>Conclusion: </strong>Subglottic stenosis is still a challenging condition to manage. The authors describe a single-center experience approach dealing with these conditions. Long-term follow-up for these cases is mandatory as the recurrence rate is still high.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A unique presentation of pericardial epithelioid angiosarcoma with multifaceted complications. 心包上皮样血管肉瘤表现独特,并伴有多种并发症。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002521
Moied Al Sakan, Mtanyous Chihab, Ouwais Alkhateb, Omar Fakhreddine, Arafat Tfayli

Introduction and importance: Angiosarcomas are rare tumors of endothelial origin and may arise in any organ. Epithelioid angiosarcomas are a subtype of angiosarcoma that are rapidly progressive and typically fatal.

Case presentation: The authors report a case of a 25-year-old previously healthy female who presented initially for dyspnea and palpitations, on further evaluation she was found to have large bilateral pleural effusions and cardiac tamponade.

Clinical discussion: Pericardiocentesis and thoracentesis were performed alongside biopsies that revealed atypical cellular proliferation.Fluorodeoxyglucose-positron emission tomography (FDG-PET) showed avid uptake in the anterior mediastinum, perivascular, paratracheal, subcarinal and pleural lymph nodes with large FDG uptake in the bilateral pleural effusion.Mediastinoscopy was done and biopsies showed an overtly malignant, epithelioid neoplasm with foci of vaso-formation; Keeping with high-grade epithelioid angiosarcoma of the pericardium.She received six cycles of weekly paclitaxel, but imaging for abdominal pain incidentally showed evidence of metastasis to the liver and spine so she was switched to Adriamycin-Ifosfamide for which she received one cycle so far.Her hospital course was complicated by high-output pleural effusions, chylothorax, left atrial thrombus formation and an intensive care unit stay for septic shock.

Conclusion: Pericardial epithelioid angiosarcoma has been reported rarely in the literature. The authors aim to report a case of extensive metastatic pericardial epithelioid angiosarcoma in a young patient; which we believe can be an addition to the literature of a malignancy associated with poor prognosis and no definitive proven treatment regimen.

导言和重要性:血管肉瘤是一种罕见的内皮源性肿瘤,可发生于任何器官。上皮样血管肉瘤是血管肉瘤的一种亚型,进展迅速,通常是致命的:作者报告了一例 25 岁的健康女性病例,她最初因呼吸困难和心悸就诊,进一步评估后发现她双侧胸腔大量积液和心脏填塞:荧光脱氧葡萄糖正电子发射断层扫描(FDG-PET)显示前纵隔、血管周围、气管旁、心包下和胸膜淋巴结有大量 FDG 摄取,双侧胸腔积液也有大量 FDG 摄取。她接受了纵隔镜检查,活检结果显示这是一种明显恶性的上皮样肿瘤,有血管形成灶;与心包的高级别上皮样血管肉瘤保持一致。她接受了每周六个周期的紫杉醇治疗,但腹痛造影偶然显示肝脏和脊柱有转移迹象,因此她改用了阿霉素-伊福酰胺治疗,至今已接受了一个周期的治疗。她的住院过程很复杂,出现了大量胸腔积液、乳糜胸、左心房血栓形成,并因脓毒性休克住进了重症监护室:结论:心包上皮样血管肉瘤在文献中鲜有报道。作者旨在报告一例年轻患者心包上皮样血管肉瘤广泛转移的病例;我们认为,该病例为预后不良且无明确治疗方案的恶性肿瘤文献增添了新的内容。
{"title":"A unique presentation of pericardial epithelioid angiosarcoma with multifaceted complications.","authors":"Moied Al Sakan, Mtanyous Chihab, Ouwais Alkhateb, Omar Fakhreddine, Arafat Tfayli","doi":"10.1097/MS9.0000000000002521","DOIUrl":"10.1097/MS9.0000000000002521","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Angiosarcomas are rare tumors of endothelial origin and may arise in any organ. Epithelioid angiosarcomas are a subtype of angiosarcoma that are rapidly progressive and typically fatal.</p><p><strong>Case presentation: </strong>The authors report a case of a 25-year-old previously healthy female who presented initially for dyspnea and palpitations, on further evaluation she was found to have large bilateral pleural effusions and cardiac tamponade.</p><p><strong>Clinical discussion: </strong>Pericardiocentesis and thoracentesis were performed alongside biopsies that revealed atypical cellular proliferation.Fluorodeoxyglucose-positron emission tomography (FDG-PET) showed avid uptake in the anterior mediastinum, perivascular, paratracheal, subcarinal and pleural lymph nodes with large FDG uptake in the bilateral pleural effusion.Mediastinoscopy was done and biopsies showed an overtly malignant, epithelioid neoplasm with foci of vaso-formation; Keeping with high-grade epithelioid angiosarcoma of the pericardium.She received six cycles of weekly paclitaxel, but imaging for abdominal pain incidentally showed evidence of metastasis to the liver and spine so she was switched to Adriamycin-Ifosfamide for which she received one cycle so far.Her hospital course was complicated by high-output pleural effusions, chylothorax, left atrial thrombus formation and an intensive care unit stay for septic shock.</p><p><strong>Conclusion: </strong>Pericardial epithelioid angiosarcoma has been reported rarely in the literature. The authors aim to report a case of extensive metastatic pericardial epithelioid angiosarcoma in a young patient; which we believe can be an addition to the literature of a malignancy associated with poor prognosis and no definitive proven treatment regimen.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of hypertonic saline with or without hyaluronic acid among patients with cystic fibrosis: a systematic review and meta-analysis. 高渗盐水加或不加透明质酸对囊性纤维化患者的疗效:系统综述和荟萃分析。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002450
Zarghuna Khan, Muhammad O Naeem, Dr Anam Amin, Laraib Amin, Abdullah Shah, Saad Ul Khaliq, Aima Azhar, Sana Naz, Syed M Shujauddin, Muhammad A Arshad, Sarosh J Ali, Emad U Sajid, Sayed Jawad

Background: The clinical effectiveness of hypertonic saline (HS) in individuals with cystic fibrosis (CF) can be compromised by adverse effects. The objective of this study was to examine the efficacy of hyaluronic acid (HA) in mitigating these negative occurrences.

Methods: A comprehensive review of the literature was carried out using three electronic databases: Medline, Cochrane Central, and Embase. This systematic review and meta-analysis investigate the efficacy of hypertonic saline (HS) with and without hyaluronic acid (HA) in treating cystic fibrosis. Primary outcomes include the incidence of cough, throat irritation, unpleasant taste, and changes in FEV1. Our findings suggest that adding HA to HS significantly reduces adverse effects and enhances patient tolerability, marking a potential improvement in cystic fibrosis therapy. Risk ratios (RRs) and mean differences (MDs) with 95% CI were used to present evaluations. The quality of RCTs was evaluated using the Cochrane Risk of Bias Tool (CRBT). The quality of the observational study was evaluated using the Newcastle-Ottawa Scale.

Results: From the 1960 articles retrieved from the initial search, five relevant studies (n=236 patients) were included in the final analysis. Compared with patients only on HS, patients with HS and HA were significantly less likely to experience cough (RR: 0.45; 95% CI, 0.28-0.72, P=0.001), throat irritation (RR: 0.43; 95% CI, 0.22-0.81, P=0.009), and unpleasant smell (RR: 0.43; 95% CI, 0.23-0.80, P=0.09). In addition, patients with HS with HA had significantly less forced expiratory volume (FEV1) (MD: -2.97; 95% CI, -3.79--2.15, P=0.52), compared to patients only on HS. Patients on HA + HS had significantly lower rates of cough (RR: 0.45; 95% CI, 0.28-0.72, P=0.001), throat irritation (RR: 0.43; 95% CI, 0.22-0.81, P=0.009), and bad smell (RR: 0.43; 95% CI, 0.23-0.80, P=0.09) when compared to patients on HS alone. Furthermore, compared to patients solely on HS, patients with HS plus HA exhibited a substantially lower forced expiratory volume (FEV1) (MD: -2.97; 95% CI, -3.79 to -2.15, P=0.52) as well.

Conclusion: For CF patients who need ongoing HS therapy and have a history of poor therapy tolerance, adding HA is beneficial.

背景:高渗盐水(HS)对囊性纤维化(CF)患者的临床疗效可能会受到不良反应的影响。本研究旨在探讨透明质酸(HA)在减轻这些不良反应方面的功效:方法:使用三个电子数据库对文献进行了全面审查:Medline、Cochrane Central 和 Embase。本系统综述和荟萃分析调查了含或不含透明质酸(HA)的高渗盐水(HS)治疗囊性纤维化的疗效。主要结果包括咳嗽发生率、咽喉刺激、异味和 FEV1 的变化。我们的研究结果表明,在 HS 中添加 HA 可显著减少不良反应,提高患者的耐受性,这标志着囊性纤维化治疗的潜在改进。评估采用风险比(RRs)和平均差(MDs)以及 95% CI。采用科克伦偏倚风险工具(Cochrane Risk of Bias Tool,CRBT)对研究性临床试验的质量进行评估。观察性研究的质量采用纽卡斯尔-渥太华量表进行评估:在最初检索到的 1960 篇文章中,有 5 项相关研究(n=236 名患者)被纳入最终分析。与只服用 HS 的患者相比,服用 HS 和 HA 的患者出现咳嗽(RR:0.45;95% CI:0.28-0.72,P=0.001)、咽喉不适(RR:0.43;95% CI:0.22-0.81,P=0.009)和难闻气味(RR:0.43;95% CI:0.23-0.80,P=0.09)的几率明显降低。此外,与只服用 HS 的患者相比,服用 HA 的 HS 患者的用力呼气容积(FEV1)明显减少(MD:-2.97;95% CI:-3.79--2.15,P=0.52)。与单纯服用 HS 的患者相比,服用 HA + HS 的患者的咳嗽(RR:0.45;95% CI:0.28-0.72,P=0.001)、咽喉刺激(RR:0.43;95% CI:0.22-0.81,P=0.009)和异味(RR:0.43;95% CI:0.23-0.80,P=0.09)发生率明显降低。此外,与单纯使用 HS 的患者相比,使用 HS 加 HA 的患者的用力呼气容积(FEV1)也大大降低(MD:-2.97;95% CI,-3.79 至 -2.15,P=0.52):对于需要持续接受 HS 治疗且治疗耐受性较差的 CF 患者来说,添加 HA 是有益的。
{"title":"Effectiveness of hypertonic saline with or without hyaluronic acid among patients with cystic fibrosis: a systematic review and meta-analysis.","authors":"Zarghuna Khan, Muhammad O Naeem, Dr Anam Amin, Laraib Amin, Abdullah Shah, Saad Ul Khaliq, Aima Azhar, Sana Naz, Syed M Shujauddin, Muhammad A Arshad, Sarosh J Ali, Emad U Sajid, Sayed Jawad","doi":"10.1097/MS9.0000000000002450","DOIUrl":"10.1097/MS9.0000000000002450","url":null,"abstract":"<p><strong>Background: </strong>The clinical effectiveness of hypertonic saline (HS) in individuals with cystic fibrosis (CF) can be compromised by adverse effects. The objective of this study was to examine the efficacy of hyaluronic acid (HA) in mitigating these negative occurrences.</p><p><strong>Methods: </strong>A comprehensive review of the literature was carried out using three electronic databases: Medline, Cochrane Central, and Embase. This systematic review and meta-analysis investigate the efficacy of hypertonic saline (HS) with and without hyaluronic acid (HA) in treating cystic fibrosis. Primary outcomes include the incidence of cough, throat irritation, unpleasant taste, and changes in FEV1. Our findings suggest that adding HA to HS significantly reduces adverse effects and enhances patient tolerability, marking a potential improvement in cystic fibrosis therapy. Risk ratios (RRs) and mean differences (MDs) with 95% CI were used to present evaluations. The quality of RCTs was evaluated using the Cochrane Risk of Bias Tool (CRBT). The quality of the observational study was evaluated using the Newcastle-Ottawa Scale.</p><p><strong>Results: </strong>From the 1960 articles retrieved from the initial search, five relevant studies (<i>n</i>=236 patients) were included in the final analysis. Compared with patients only on HS, patients with HS and HA were significantly less likely to experience cough (RR: 0.45; 95% CI, 0.28-0.72, <i>P</i>=0.001), throat irritation (RR: 0.43; 95% CI, 0.22-0.81, <i>P</i>=0.009), and unpleasant smell (RR: 0.43; 95% CI, 0.23-0.80, <i>P</i>=0.09). In addition, patients with HS with HA had significantly less forced expiratory volume (FEV1) (MD: -2.97; 95% CI, -3.79--2.15, <i>P</i>=0.52), compared to patients only on HS. Patients on HA + HS had significantly lower rates of cough (RR: 0.45; 95% CI, 0.28-0.72, <i>P</i>=0.001), throat irritation (RR: 0.43; 95% CI, 0.22-0.81, <i>P</i>=0.009), and bad smell (RR: 0.43; 95% CI, 0.23-0.80, <i>P</i>=0.09) when compared to patients on HS alone. Furthermore, compared to patients solely on HS, patients with HS plus HA exhibited a substantially lower forced expiratory volume (FEV1) (MD: -2.97; 95% CI, -3.79 to -2.15, <i>P</i>=0.52) as well.</p><p><strong>Conclusion: </strong>For CF patients who need ongoing HS therapy and have a history of poor therapy tolerance, adding HA is beneficial.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444569/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of proteins' expression pathway and the effective miRNAs for the treatment of human papillomavirus-induced cervical cancer: in-silico analyses-experimental research. 鉴定治疗人类乳头瘤病毒诱发的宫颈癌的蛋白质表达途径和有效的 miRNAs:硅内分析-实验研究。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002513
Marzieh Monemi, Lida Garrosi, Samira Mirzaei, Bahar Farhadi, Reza Ataee Disfani, Mohammad Reza Zabihi, Mohammad Akhoondian, Pooyan Ghorbani Vajargah, Alireza Khorshid, Samad Karkhah

Introduction: Cervical cancer is the fourth most common cancer in women. The risk factors for cervical cancer include human papillomavirus (HPV) infection, age, smoking, number of pregnancies, use of oral contraceptives, and diet. However, long-term HPV infection appears to be the main risk factor for developing cervical cancer. This in-silico analysis aims to identify the expression network of proteins and the miRNAs that play a role in the development of HPV-induced cervical cancer.

Methods: The critical proteins and miRNAs were extracted using the DisGeNET and miRBase databases. String and Gephi were applied to the network analysis. The GTEx web tool was utilized to Identify tissue expression levels. The Enrichr website was used to explore the molecular function and pathways of found genes.

Results: Ten proteins, TP53, MYC, AKT1, TNF, IL6, EGFR, STAT3, CTNNB1, ESR1, and JUN, were identified as the most critical shared gene network among cervical cancer and HPV. Seven miRNAs were found, including hsa-mir-146a, hsa-mir-27, hsa-mir-203, hsa-mir-126, hsa-mir-145, hsa-mir-944, and hsa-mir-93, which have a common expression in cervical cancer and HPV.

Conclusion: Overall, the gene network, including TP53, MYC, AKT1, TNF, IL6, EGFR, STAT3, CTNNB1, ESR1, and JUN, and Also, hsa-mir-145, hsa-mir-93, hsa-mir-203, and hsa-mir-126 can be regarded as a gene expression pathway in HPV-induced cervical cancer.

导言宫颈癌是女性第四大常见癌症。宫颈癌的风险因素包括人类乳头瘤病毒(HPV)感染、年龄、吸烟、怀孕次数、口服避孕药和饮食。然而,HPV 长期感染似乎是罹患宫颈癌的主要风险因素。本研究旨在确定在 HPV 诱导的宫颈癌发展过程中发挥作用的蛋白质表达网络和 miRNA:方法:利用 DisGeNET 和 miRBase 数据库提取关键蛋白质和 miRNA。应用 String 和 Gephi 进行网络分析。利用 GTEx 网络工具确定组织表达水平。Enrichr网站用于探索发现基因的分子功能和通路:结果:TP53、MYC、AKT1、TNF、IL6、表皮生长因子受体、STAT3、CTNNB1、ESR1 和 JUN 这十个蛋白被确定为宫颈癌和 HPV 之间最关键的共享基因网络。研究还发现了7种miRNA,包括hsa-mir-146a、hsa-mir-27、hsa-mir-203、hsa-mir-126、hsa-mir-145、hsa-mir-944和hsa-mir-93,它们在宫颈癌和HPV中具有共同的表达:总体而言,包括TP53、MYC、AKT1、TNF、IL6、表皮生长因子受体、STAT3、CTNNB1、ESR1和JUN在内的基因网络,以及hsa-mir-145、hsa-mir-93、hsa-mir-203和hsa-mir-126可被视为HPV诱发宫颈癌的基因表达通路。
{"title":"Identification of proteins' expression pathway and the effective miRNAs for the treatment of human papillomavirus-induced cervical cancer: in-silico analyses-experimental research.","authors":"Marzieh Monemi, Lida Garrosi, Samira Mirzaei, Bahar Farhadi, Reza Ataee Disfani, Mohammad Reza Zabihi, Mohammad Akhoondian, Pooyan Ghorbani Vajargah, Alireza Khorshid, Samad Karkhah","doi":"10.1097/MS9.0000000000002513","DOIUrl":"10.1097/MS9.0000000000002513","url":null,"abstract":"<p><strong>Introduction: </strong>Cervical cancer is the fourth most common cancer in women. The risk factors for cervical cancer include human papillomavirus (HPV) infection, age, smoking, number of pregnancies, use of oral contraceptives, and diet. However, long-term HPV infection appears to be the main risk factor for developing cervical cancer. This in-silico analysis aims to identify the expression network of proteins and the miRNAs that play a role in the development of HPV-induced cervical cancer.</p><p><strong>Methods: </strong>The critical proteins and miRNAs were extracted using the DisGeNET and miRBase databases. String and Gephi were applied to the network analysis. The GTEx web tool was utilized to Identify tissue expression levels. The Enrichr website was used to explore the molecular function and pathways of found genes.</p><p><strong>Results: </strong>Ten proteins, TP53, MYC, AKT1, TNF, IL6, EGFR, STAT3, CTNNB1, ESR1, and JUN, were identified as the most critical shared gene network among cervical cancer and HPV. Seven miRNAs were found, including hsa-mir-146a, hsa-mir-27, hsa-mir-203, hsa-mir-126, hsa-mir-145, hsa-mir-944, and hsa-mir-93, which have a common expression in cervical cancer and HPV.</p><p><strong>Conclusion: </strong>Overall, the gene network, including TP53, MYC, AKT1, TNF, IL6, EGFR, STAT3, CTNNB1, ESR1, and JUN, and Also, hsa-mir-145, hsa-mir-93, hsa-mir-203, and hsa-mir-126 can be regarded as a gene expression pathway in HPV-induced cervical cancer.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etiology and epidemiology of acute exacerbations of chronic obstructive pulmonary disease in Eastern Nepal: a narrative review. 尼泊尔东部慢性阻塞性肺病急性加重的病因和流行病学:叙述性综述。
IF 1.7 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-10-01 DOI: 10.1097/MS9.0000000000002520
Pratik Adhikari

This narrative review aims to examine the etiology and epidemiology of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in Eastern Nepal. A systematic search was conducted to identify relevant studies published in English, focusing on combinations of keywords such as "acute exacerbation of chronic obstructive pulmonary disease," "AECOPD," "Nepal," "etiology," "epidemiology," "environmental exposure," "comorbidities," and "socioeconomic factors." Synthesizing findings from recent studies, it highlights the multifactorial nature of AECOPD, including the roles of respiratory infections, environmental exposures, and comorbidities. Key findings indicate that respiratory infections (both viral and bacterial) and non-infectious factors such as air pollution and biomass fuel combustion significantly contribute to AECOPD. Socio-economic factors, particularly among women using traditional biomass fuels and engaged in smoking, also play a critical role. The review emphasizes the need for targeted interventions and preventive strategies to manage AECOPD effectively in this region. Conclusions suggest that understanding local patterns of AECOPD etiology is crucial for developing region-specific interventions to reduce exposure to risk factors and manage comorbidities, thereby improving clinical outcomes and reducing healthcare utilization.

本叙述性综述旨在研究尼泊尔东部慢性阻塞性肺疾病(AECOPD)急性加重的病因学和流行病学。我们进行了系统性检索,以确定用英语发表的相关研究,重点关注 "慢性阻塞性肺疾病急性加重"、"AECOPD"、"尼泊尔"、"病因学"、"流行病学"、"环境暴露"、"合并症 "和 "社会经济因素 "等关键词的组合。该报告综合了近期的研究结果,强调了 AECOPD 的多因素性质,包括呼吸道感染、环境暴露和合并症的作用。主要研究结果表明,呼吸道感染(包括病毒感染和细菌感染)以及空气污染和生物质燃料燃烧等非感染因素是导致AECOPD的重要原因。社会经济因素,尤其是使用传统生物质燃料和吸烟妇女的社会经济因素,也起着至关重要的作用。综述强调,有必要采取有针对性的干预措施和预防策略,以有效管理该地区的 AECOPD。结论表明,了解当地的 AECOPD 病因模式对于制定针对该地区的干预措施至关重要,这些干预措施可减少暴露于风险因素的机会并控制合并症,从而改善临床疗效并减少医疗保健的使用。
{"title":"Etiology and epidemiology of acute exacerbations of chronic obstructive pulmonary disease in Eastern Nepal: a narrative review.","authors":"Pratik Adhikari","doi":"10.1097/MS9.0000000000002520","DOIUrl":"10.1097/MS9.0000000000002520","url":null,"abstract":"<p><p>This narrative review aims to examine the etiology and epidemiology of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in Eastern Nepal. A systematic search was conducted to identify relevant studies published in English, focusing on combinations of keywords such as \"acute exacerbation of chronic obstructive pulmonary disease,\" \"AECOPD,\" \"Nepal,\" \"etiology,\" \"epidemiology,\" \"environmental exposure,\" \"comorbidities,\" and \"socioeconomic factors.\" Synthesizing findings from recent studies, it highlights the multifactorial nature of AECOPD, including the roles of respiratory infections, environmental exposures, and comorbidities. Key findings indicate that respiratory infections (both viral and bacterial) and non-infectious factors such as air pollution and biomass fuel combustion significantly contribute to AECOPD. Socio-economic factors, particularly among women using traditional biomass fuels and engaged in smoking, also play a critical role. The review emphasizes the need for targeted interventions and preventive strategies to manage AECOPD effectively in this region. Conclusions suggest that understanding local patterns of AECOPD etiology is crucial for developing region-specific interventions to reduce exposure to risk factors and manage comorbidities, thereby improving clinical outcomes and reducing healthcare utilization.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Medicine and Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1